Immunotherapy Company's Q2 Revenue 'Handily Beats' H.C. Wainwright's Projection

H.C. Wainwright reiterated its Buy rating and 12-month price target of $13 per share on Inovio. The stock is currently trading at around $5.43 per share.

1 2
View single page >> |

Disclosure: 

1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise reports as an independent contractor. She or members of her household own ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.